Adenosine A2A Receptor Occupancy by Long-Term Istradefylline Administration in Parkinson's Disease. Ishibashi K, Miura Y, Wagatsuma K, Toyohara J, et al. Mov Disord 2020 Nov 16. doi: 10.1002/mds.28378.

Read + Share

Amedeo Smart

Independent Medical Education

Ishibashi K, Miura Y, Wagatsuma K, Toyohara J, et al. Adenosine A2A Receptor Occupancy by Long-Term Istradefylline Administration in Parkinson's Disease. Mov Disord 2020 Nov 16. doi: 10.1002/mds.28378.
PMID: 33200448